Morgan Stanley cuts Equifax price target to $205 from $225; keeps Overweight

Negative analyst action. On October 13, Morgan Stanley’s Toni Kaplan cut the target to $205 from $225 and kept Overweight. The firm’s business-services earnings preview said organic-growth weakness could be attributed to AI; it said investor concerns about AI disruption were largely reflected in share prices.